Woman speaking and looking to the right of the screen.

Our approach

Boston Scientific is committed to driving meaningful innovation for all patients, and Close the Gap supports that mission

Close the Gap initiative overview

Health equity interventions

1. Health System Improvement

Close the Gap collaborates with healthcare professionals (Boston Scientific customers) to uncover care disparities and build action plans that close cardiovascular treatment gaps. Our program is called: Heart and Vascular (HAV) Health Equity Level-up Program (HELP). ​

2. Clinical Trial Diversity

Close the Gap collaborates with Boston Scientific’s clinical research leaders on Advancing Clinical Trials for Enhanced Diversity (ACTED) – helping to identify and address opportunities to improve enrollment for underrepresented patient populations.​

3. Equitable Care Advocacy

Close the Gap shares best practices and insights with healthcare professionals and medical device peers to inform and inspire collective action and improve the diverse patient experience.

Explore resources to help empower diverse patients on their healthcare journey

Explore education and insights to help improve the diverse patient experience

Close the Gap’s 2023 impact​

“Close the Gap creates lasting impact by sharing opportunities and championing meaningful action to reach more people needing life-changing care.” — Paige Bingham, Director, Close the Gap​

Health System Improvement

~55,000

women & people of color identified ​as at risk of missing equitable care

74

healthcare provider customers collaborated with Close the Gap

40

healthcare provider customers implemented an action plan

Clinical Trial Diversity

8

​BSC clinical trials partnered with CTG to increase diverse representation*​

1,500+

diverse patients enrolled* in BSC clinical trials collaborating with CTG

3

BSC trials worked with CTG to develop FDA diversity plans**

Equitable Care Advocacy

4

cardiovascular and health equity education summits

650+

Black community leaders engaged to champion cardiovascular health equity

31

Health equity activities to share our expertise and best practices

*4 of the 8 trials were enrolling patients in 2023 and have enrolled  over 1,500 women and people of color. Enrolling trials included: AVANT-GUARD, ELEGANCE, HEAL-LAA, ROWAN, from start of enrollment through 12/31/2023​.
​**FDA diversity plans submitted for: AVANT GUARD, FROZEN PMS, SPACE-IT​

Our dedicated team

Headshot of Paige Bingham.

Paige Bingham
Director

Headshot of Rasika Boice.

Rasika Boice
Sr. Integrated Marketing Communications Strategist

Headshot of Heather Brown.

Heather Brown
Health Equity Project Manager

Headshot of Leigh Wynne.

Leigh Halloran
Senior Health Equity Consultant

Headshot of Jeri'Ann Hiller.

Jeri’Ann Hiller
Senior Health Equity Manager

Headshot of Keana Jennissen.

Keana Jennissen
Associate Marketing Director​

Headshot of Iñaki Martin Cossio.

Iñaki Martin Cossio
Clinical Manager, Health Equity

Headshot of Trish Solliday.

Trish Solliday
Health Equity Manager